Global team, global experience
MACS has expansive experience and success working across global markets, with 94% of projects coming from repeat clients.
Legend:
🟨Gold—regions with experience; 🚩Red markers—offices
We are a global team of strategy experts with a shared passion for shaping value, navigating market access and optimizing price for pharma and biotech innovators.
MACS has expansive experience and success working across global markets, with 94% of projects coming from repeat clients.
Legend:
🟨Gold—regions with experience; 🚩Red markers—offices
We enable our clients to gain access to the maximum number of appropriate patients at the optimal reimbursed price. We do this by integrating payer insights early and often to determine the acceptability of your product’s value story before payers define it for you.
Market access is understanding how payers value your product. A persuasive value story succinctly identifies your unique selling proposition and sparks interest, supported by credible claims that resonate with stakeholders’ behaviors and goals. We help you understand how payers value your product, how to drive the narrative of value, and how best to communicate this value on common ground.
Who determines market access success? Payers. A payer is any stakeholder who determines or influences the evaluation and purchase decision of your product. You can optimize your market access opportunity by understanding the reimbursement landscape. Build your market access strategy in a proactive and collaborative way that integrates payer insights and our expertise throughout the engagement.
What are payers most often concerned about? Price. ​The economics of pricing strategy in the global pharmaceutical industry is a constantly changing science. Our leadership are experts in setting launch price, in-line price and end of life price strategy. We help you identify the optimal pricing bands and the trade-offs in volume and access with different pricing strategies.
Effective payer engagement is about finding the right advisors to inform your specific needs and understanding their decision-making behavior. We have long-standing relationships with key market access decision makers. We have found that multiple inputs to a conversation result in a convergence toward actionable insights. Our team is well-versed in having these dynamic conversations to ensure you receive well-reasoned responses.
The pricing and reimbursement arena is ever evolving. You must keep abreast of the dynamics and understand the implications. Speaking a common market access language within your organization is crucial to your success. We have the resources and experience to ensure your well-crafted market access strategy is translated into execution, both for your internal teams and field forces.
Life science industry partnerships can be contentious. The partners occasionally have different views of the world and have no choice but to pursue legal action. We have successfully been engaged to act as an expert witness on pricing and market access issues. We produce the supporting evidence to communicate your position and will stand strong against any competing expert witnesses.
We deploy our deep capabilities across the entire commercialization process, leveraging decades of experience in the life sciences consultancy sector.
How far could your product go with dedicated industry experts who will fully develop and execute a comprehensive commercial strategy?
With this offering, we bring the opportunity to deepen and derive insights from managed care data such as payer data, manufacturer hub data, claims, and more; applied across various functions from account managers to high level strategy development.
Our PAYER Q2 program allows you to ask our payer panel a key business question, we then conduct one on one interviews with our payer panelists and provide you with verbatim feedback and strategic implications on that topic in as quickly as 7 days.